cro.directory
← Compare landing

ChemPartner vs Sygnature Discovery

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryChemPartnerSygnature Discovery
SummaryGlobal preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide.Sygnature Discovery is an integrated drug discovery contract research organization offering target identification, hit-to-lead, lead optimization, computational design, protein science, and in vivo pharmacology services. The company partners with biotech and pharma clients across the US, Canada, the UK, and Europe.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • Protein Engineering
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Carcinogenicity Studies
  • DART (Reproductive & Developmental Toxicology)
  • Specialized & Large-Animal Models
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Flow Cytometry Services
  • Regulatory Affairs
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Translational Research
  • Pathology & Histology Services
  • Discovery Research
  • Target Identification & Validation
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • Protein Engineering
  • In Vitro ADME / DMPK
  • Preclinical In Vivo Studies
  • In Vivo PK / PD Studies
  • Bioinformatics & Data Science
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • Peptide
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Peptide
Indications
  • Oncology
  • Immunology
  • Neurology
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
Phases
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Discovery
  • Preclinical (General)
Sourcing models
  • Full-Service Outsourcing (FSO)
Data not yet provided.
Locations
  • Boston Center of Excellence, Watertown, Massachusetts, USA
  • United Kingdom, Sandwich, Kent, United Kingdom
  • Europe, Copenhagen, Denmark, Denmark
  • Chengdu, Chengdu, China
  • Jiangsu, Jiangsu, China
  • Shanghai, Shanghai, China
  • Malaysia, Malaysia, Malaysia
  • Australia, Australia, Australia
  • Copenhagen, Copenhagen, Denmark
  • Malaysia, Malaysia
  • Jiangsu, Jiangsu, China
  • Australia, Australia
  • UK site, United Kingdom
  • Canada site, Canada
Certifications
  • GLP · Identifier: GLP Compliant
  • GMP · Identifier: cGMP Manufacturing / GMP Production
Data not yet provided.

Find similar companies

ChemPartner alternatives · Sygnature Discovery alternatives

Markdown mirror: /compare/chempartner/sygnaturediscovery.md